Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Merck
McKinsey
Dow
Express Scripts

Last Updated: August 19, 2022

Investigational Drug Information for Netupitant


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Netupitant?

Netupitant is an investigational drug.

There have been 16 clinical trials for Netupitant. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2021.

The most common disease conditions in clinical trials are Vomiting, Nausea, and Breast Neoplasms. The leading clinical trial sponsors are Helsinn Healthcare SA, National Cancer Institute (NCI), and Consorzio Oncotech.

There are one hundred and forty-seven US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Netupitant
TitleSponsorPhase
Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)Helsinn Healthcare SAPhase 4
Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast CancerInstituto Brasileiro de Controle do CancerPhase 2
Low Dose Aprepitant for Patients Receiving CarboplatinJacobi Medical CenterPhase 2

See all Netupitant clinical trials

Clinical Trial Summary for Netupitant

Top disease conditions for Netupitant
Top clinical trial sponsors for Netupitant

See all Netupitant clinical trials

US Patents for Netupitant

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Netupitant See Plans and Pricing Crystalline forms of fosnetupitant Helsinn Healthcare SA (Lugano/Pazzallo, CH) See Plans and Pricing
Netupitant See Plans and Pricing Cyclohexyl pyridine derivative KISSEI PHARMACEUTICAL CO., LTD. (Matsumoto, Nagano, JP) See Plans and Pricing
Netupitant See Plans and Pricing .beta.-substituted .beta.-amino acids and analogs as chemotherapeutic agents and uses thereof Quadriga Biosciences, Inc. (Los Altos, CA) See Plans and Pricing
Netupitant See Plans and Pricing Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) See Plans and Pricing
Netupitant See Plans and Pricing Method for cancer cell reprogramming STC.UNM (Albuquerque, NM) See Plans and Pricing
Netupitant See Plans and Pricing Bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use The Trustees of The University of Pennsylvania (Philadelphia, PA) See Plans and Pricing
Netupitant See Plans and Pricing Estrogen-related receptor alpha based protac compounds and associated methods of use Yale University (New Haven, CT) Arvinas, Inc. (New Haven, CT) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Netupitant

Drugname Country Document Number Estimated Expiration Related US Patent
Netupitant Australia AU2016335060 2035-10-06 See Plans and Pricing
Netupitant Canada CA2996466 2035-10-06 See Plans and Pricing
Netupitant China CN108137626 2035-10-06 See Plans and Pricing
Netupitant European Patent Office EP3359547 2035-10-06 See Plans and Pricing
Netupitant Japan JP2018531249 2035-10-06 See Plans and Pricing
Netupitant Japan JP6880009 2035-10-06 See Plans and Pricing
Netupitant South Korea KR20180064453 2035-10-06 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Merck
McKinsey
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.